Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2
Por um escritor misterioso
Descrição
Open science discovery of potent noncovalent SARS-CoV-2 main
Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2
Crystallographic structure of wild-type SARS-CoV-2 main protease
RCSB PDB - 7L14: CRYSTAL STRUCTURE OF THE SARS-COV-2(2019-NCOV
Potential SARS-CoV-2 main protease inhibitors - ScienceDirect
Frontiers An Integrated Computational and Experimental Approach
Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity
Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2
Development of highly potent non-covalent inhibitors of SARS-CoV-2
Open science discovery of potent noncovalent SARS-CoV-2 main
Mechanism and inhibition of the papain‐like protease, PLpro, of
Inhibition Mechanism of SARS‐CoV‐2 Main Protease with Ketone‐Based
Hit Expansion of a Noncovalent SARS-CoV-2 Main Protease Inhibitor